ReviewImmunoHorizons2026
Nasal humoral immunity: the first line of protection against respiratory pathogens.
Review in ImmunoHorizons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ASPIRE to new horizons.ImmunoHorizons · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The nasal cavity is the first site of infection for respiratory pathogens, and control of pathogens at this site is critical for limiting disease progression. Mucosal immunity in the respiratory tract has historically been studied in the lungs despite lung infections typically arising as a result of lack of pathogen control in the upper respiratory tract. However, the generation of vaccines to prevent infection and block transmission requires an understanding of how immune responses are generated and maintained within the nasal cavity. Recently, a concerted research effort to understand immune responses in the nasal cavity and upper respiratory tract has revealed new insight into how local immune responses are generated and help to control respiratory pathogens. Here, we discuss these recent advances and outstanding questions in our understanding of humoral immunity within the nasal cavity and upper respiratory tract.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.